Nucleotide pyrophosphatase/phosphodiesterases (NPPs) including NPP1 and NPP2/ ATX as important drug targets: A patent review (2015-2020)

磷酸二酯酶 药品 药物发现 药理学 体内 生物 医学 酶 生物信息学 生物化学 生物技术
作者
Sehrish Bano,Mariya al‐Rashida,Rima D. Alharthy,Imtiaz Ali Khan,Jamshed Iqbal
出处
期刊:Expert Opinion on Therapeutic Patents [Taylor & Francis]
卷期号:32 (7): 743-751 被引量:4
标识
DOI:10.1080/13543776.2022.2058874
摘要

Ectobucleotidases are a broad class of extracellular nucleotide and nucleoside hydrolyzing enzymes. Since they play a crucial role in mediating purinergic cell signalling, they are promising therapeutic targets for treatment of a range of disorders, including fibrosis, tumor metastasis, inflammation, multiple sclerosis, and autoimmune diseases. Hence selective inhibtors of ectonulceotidases are of great interest for therapeutic intervention.Many compounds have demonstrated promising inhibitory potential against ecto-nucleotide pyrophosphatase/phosphodiesterases (NPPs). The chemistry and clinical applications of NPP inhibitors patented between 2015 and 2020 are discussed in this review.In recent years, there has been a lot of effort towards finding effective and selective inhibitors of NPPs. Even though a number of inhibitors are known, only a few in vivo investigations have been published. In addition to IOA-289, which has passed Phase Ia clinical trials, potent NPP2/ATX inhibitor compounds such as BLD-0409, IPF and BBT-877 have been placed in phase I clinical studies. Some of the most promising NPP2/ATX inhibitors in recent years are closely related analogs of previously known inhibitors, such as PF-8380. Knowledge of the structure activity relationship of such promising inhibitors can potentially translate into the discovery of more potent and effective inhibitors of NPP.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
AxiE完成签到 ,获得积分10
刚刚
诚心元菱发布了新的文献求助10
刚刚
嘻嘻哈哈的应助被Prophet采纳,获得10
刚刚
乐乐的应助被务实的立诚采纳,获得10
刚刚
时平谊发布了新的文献求助30
1秒前
1212122完成签到,获得积分10
1秒前
Wenlia的应助被Han采纳,获得10
1秒前
天天向上的应助被风吹麦浪采纳,获得10
2秒前
科研通AI6.2的应助被风吹麦浪采纳,获得10
2秒前
3秒前
5秒前
赵梦杰完成签到,获得积分10
6秒前
wanci的应助被科研通管家采纳,获得10
6秒前
7秒前
DW的应助被科研通管家采纳,获得10
7秒前
Hello的应助被zr采纳,获得10
7秒前
syvshc的应助被科研通管家采纳,获得10
7秒前
fantasy的应助被科研通管家采纳,获得10
7秒前
小马甲的应助被科研通管家采纳,获得10
7秒前
丘比特的应助被科研通管家采纳,获得10
7秒前
7秒前
molihuakai的应助被科研通管家采纳,获得10
7秒前
7秒前
在水一方的应助被科研通管家采纳,获得10
8秒前
molihuakai的应助被科研通管家采纳,获得10
8秒前
完美世界的应助被科研通管家采纳,获得10
8秒前
今后的应助被科研通管家采纳,获得10
8秒前
Owen的应助被科研通管家采纳,获得10
8秒前
酷波er的应助被科研通管家采纳,获得10
8秒前
清秀语蝶的应助被科研通管家采纳,获得30
8秒前
852的应助被科研通管家采纳,获得10
8秒前
超人Steiner完成签到 ,获得积分10
8秒前
英俊的铭的应助被科研通管家采纳,获得10
9秒前
9秒前
orixero的应助被科研通管家采纳,获得10
9秒前
NexusExplorer的应助被科研通管家采纳,获得10
9秒前
zzzq完成签到,获得积分10
9秒前
CC发布了新的文献求助10
9秒前
CodeCraft的应助被科研通管家采纳,获得10
9秒前
Maestro_S的应助被科研通管家采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186629
求助须知:如何正确求助?哪些是违规求助? 9574913
关于积分的说明 21838832
捐赠科研通 7784206
什么是DOI,文献DOI怎么找? 3434808
关于科研通互助平台的介绍 2559183
邀请新用户注册赠送积分活动 2481582